TANNER BODILY: Open Payments
NPI 1356957039 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 38 payments from 12 companies in 2025. Trend: 2023 $429 · 2024 $473 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 10 | $139 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| ABBVIE INC. | 5 | $107 |
| Lilly USA, LLC | 4 | $81 |
| Antares Pharma, Inc. | 4 | $60 |
| Novo Nordisk Inc | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
Products named: FANAPT, ZENPEP, QULIPTA, MOUNJARO, XYOSTED, Wegovy, GVOKE HYPOPEN, VOWST.
Industry payments across ID — which companies pay providers there.
